Archive:drug marketing

• A Hard Look at Prescribing: Program Co-Director Comments on New Opioid Study

  This February, Program Co-Director Adriane Fugh-Berman and her colleague, Judy Butler, authored an article breaking down a new study on opioid prescribing and use disorders. According to the research

  Category: News Tags: drug marketing, pharmedout, program director, Publications, research

• History Repeating? Program Co-Director Comments on “Non-Addictive” Pain Pill in The Washington Post

  This week, Dr. Adriane Fugh-Berman, Co-Director of the M.S. HAPI program, commented on a new pain pill set for FDA review this January. The drug is non-opioid and aims to be an alternative to pre

  Categories: Announcements, News Tags: drug marketing, program director, Publications, research

• Advocacy in Action: PharmedOut Organizes a Letter Challenging “Dangerous Disinformation”

  A recent STAT news article covers Program Co-Director Dr. Adriane Fugh-Berman's organization, PharmedOut, which has organized a letter signed by multiple experts on women's health "demanding that the

  Category: News Tags: drug marketing, pharmedout, program director, Publications

• “A New Dystopic Era”: Dr. Fugh-Berman on Pharmaceutical Companies Selling Direct

  Dr. Fugh-Berman and her colleague at PharmedOut, Judy Butler, have just published an opinion piece in STAT news on an alarming new pharmaceutical practice: selling prescription drugs directly to cons

  Category: News Tags: drug marketing, pharmedout, program director, Publications

• Peer Reviewers Made $1 Billion in 3 Years: Dr. Fugh-Berman Featured in MedPage Today on Medical Journal Financial Conflicts

  More than half of peer reviewers for four top medical journals received payments from drug and medical device manufacturers, totaling $1.06 billion, from 2020 to 2022, according to an analysis of th

  Categories: Advocacy, News Tags: drug marketing, pharmedout, program director, Publications

• Drug Company Tricks: Patricia Bencivenga ’21 publishes Op-Ed in the Pittsburgh Post-Gazette

  Patricia Bencivenga '21 recently published an Op-Ed in the Pittsburgh Post Gazette alongside Judy Butler on "Drug company tricks: Gaslighting the worried well into becoming the worried sick." Patrici

  Category: News Tags: drug marketing, pharmedout, Publications, research, student spotlight

• Dangerous Fentanyl “Candy” Off the Market: Program Co-Director Adriane Fugh-Berman Published in The Kansas City Star

  Last week, Program Co-Director Adriane Fugh-Berman published an opinion piece with PharmedOut colleague Judy Butler in The Kansas City Star. The piece covers the rise and fall of fentanyl lollipops,

  Categories: News, News Story Tags: drug marketing, pharmedout, program director, Publications, research

• Psychosis or Marketing Tactic? Daisy Daeschler ’21 Published in the International Journal of Social Determinants of Health and Health Services

  Daisy Daeschler '21 has just published her research with Dr. Fugh-Berman on "Parkinson's Disease Psychosis and the Marketing of Pimavanserin." In the study, Daeschler and Fugh-Berman examine tren

  Category: News Tags: drug marketing, Publications, research, student spotlight

• Deceptive Drug Samples: Student Emily Alagha Published in Journal of Pharmaceutical Policy and Practice

  Emily Alagha, a HAPI student, published an article with Dr. Fugh-Berman in the Journal of Pharmaceutical Policy and Practice. The article, Pharmaceutical marketing: the example of drug samples, revie

  Category: News Tags: drug marketing, Publications, research, student spotlight

• Pathologizing Ageing: Patricia Bencivenga ’21 publishes Op-Ed in the Baltimore Sun

  Patricia Bencivenga '21 recently published an Op-Ed in the Baltimore Sun alongside Program Director Dr. Adriane Fugh-Berman on unnecessary prescribing for hot flashes...and just how dangerous these d

  Category: News Tags: drug marketing, pharmedout, Publications, student spotlight